Post-operative beta-irradiation in the management of pterygium
Creators
- 1. Bio-Science Division, BAEC (Bangladesh)
- 2. Institute of Nuclear Medicine and Ultrasound, Dhaka (Bangladesh)
- 3. Center for Nuclear Medicine and Ultrasound, Mitford, Dhaka (Bangladesh)
Description
Full text: A retrospective analysis of the effectiveness of Sr-90 therapy in post-operative management of pterygium. Between June 1999 and May 2001 a total of 70 patients received beta radiation for treatment of pterygium at the Institute of Nuclear Medicine and Ultrasound, Dhaka. The patients were referred by the eye surgeons soon after excision of the lesion for beta radiation to the affected area. Hand held Sr-90 contact applicator from Amersham International was used to deliver a total dose of 2500 cGy radiation to the sclera surface in five fractions. Care was taken to anesthetize the eye(s) before each application. The patients were then followed up at one week, one month, six months and one-year interval after beta irradiation. The age range of the patients suffering from primary pterygium was 18 to 40 years. All patients underwent surgical excision with bare sclera technique. Of the patients treated 42 patients were completely lost to follow up, while 28 patients were followed up at different periods for up to 12 months. In these patients the local control rate of pterygium after irradiation was 94.6% after 12 months. Recurrence of the pterygium occurred in 5.4% of cases who were given a second course of strontium therapy. Follow- up after six months showed these patients to remain free of the disease. Associated complications were mild and included conjunctivitis. There was improvement of visual acuity in 21 patients with no evidence of cataract or ulceration noted in any of 28 patients during the 12- month follow-up period. In conclusion, beta irradiation with Sr-90 after surgical excision of pterygium was found to be a safe and cost-effective means of controlling the recurrence rate of pterygium. (author)
Availability note (English)
Also available online: www.wjnm.orgAdditional details
Publishing Information
- Journal Title
- World Journal of Nuclear Medicine
- Journal Volume
- 4
- Journal Issue
- suppl.1
- Journal Page Range
- p. S17
- ISSN
- 1450-1147
Conference
- Title
- International conference on radiopharmaceutical therapy
- Acronym
- ICRT-2005
- Dates
- 11-14 Oct 2005
- Place
- Limassol (Cyprus)
INIS
- Country of Publication
- International Atomic Energy Agency (IAEA)
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 36097253
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- BRACHYTHERAPY; CATARACTS; CONJUNCTIVITIS; COST; EYES; IRRADIATION; PATIENTS; RADIATION DOSES; RADIATION SOURCE IMPLANTS; STRONTIUM 90; SURGERY
- Descriptors DEC
- ALKALINE EARTH ISOTOPES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DISEASES; DOSES; EVEN-EVEN NUCLEI; FACE; HEAD; IMPLANTS; INTERMEDIATE MASS NUCLEI; ISOTOPES; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ORGANS; RADIATION SOURCES; RADIOISOTOPES; RADIOLOGY; RADIOTHERAPY; SENSE ORGANS; SENSE ORGANS DISEASES; STRONTIUM ISOTOPES; THERAPY; YEARS LIVING RADIOISOTOPES
Optional Information
- Notes
- Available in abstract form only, full text entered in this record